Drawing based on the label description. No photo yet.
LOPHCT 460 460 pill
Pill with imprint LOPHCT 460 460 is blue & white, capsule, 14 mm and has been identified as Metoprolol Tartrate and Hydrochlorothiazide 50 mg / 25 mg. It is used for high blood pressure and quitting smoking. It is supplied by Validus Pharmaceuticals LLC.
Metoprolol Tartrate and Hydrochlorothiazide 50 mg / 25 mg
- Imprint
- LOPHCT 460 460
- Strength
- Metoprolol Tartrate 50 mg / Hydrochlorothiazide 25 mg
- Used for
- High blood pressure and quitting smoking
- Color
- Blue, White
- Shape
- Capsule / oblong
- Size
- 14 mm
- Score
- Breaks into 2 pieces
- Form
- Tablet
- Manufacturer
- Validus Pharmaceuticals LLC
- Drug class
- Beta blocker (heart and blood pressure medicine)
- NDC
- 30698-463, 30698-463-01
Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .
Report a mistake
All Metoprolol Tartrate and Hydrochlorothiazide pills and guides
What is Metoprolol Tartrate and Hydrochlorothiazide used for?
Metoprolol Tartrate and Hydrochlorothiazide is used for high blood pressure and quitting smoking.
- Medicine type
- Beta blocker (heart and blood pressure medicine); thiazide diuretic (water pill)
Official uses from the US prescribing label
Metoprolol tartrate and hydrochlorothiazide tablets is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including metoprolol.
Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than 1 drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program's Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).
Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits. The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly.
Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (for example, patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal.
Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in black patients, and many antihypertensive drugs have additional approved indications and effects (eg, on angina, heart failure, or diabetic kidney disease). These considerations may guide selection of therapy.
Metoprolol tartrate and hydrochlorothiazide tablets may be administered with other antihypertensive agents.
Limitation of Use
Metoprolol tartrate and hydrochlorothiazide tablets is not indicated for initial therapy of hypertension. If the fixed combination represents the dose titrated to the individual patient's needs, therapy with the fixed combination may be more convenient than with the separate components.
From the FDA-approved label on DailyMed (published Apr 10, 2025).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- Your pill shows LOPHCT 460 460. The parts can be split between the two sides, so turn the pill over and check both.
- It is blue & white, capsule, 14 mm.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Sold under the brand name Lopressor HCT.
Ingredients
Active: Metoprolol Tartrate, Hydrochlorothiazide
Inactive: Cellulose, Microcrystalline, Silicon Dioxide, Sodium Starch Glycolate Type A Potato, Fd&c Blue No. 1, Magnesium Stearate, Lactose, Unspecified Form, Polyethylene Glycol, Unspecified, Propylene Glycol, Povidone, Starch, Corn, Stearic Acid, Sucrose
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
AA17A
Lenalidomide 2.5 mg
Blue & white, capsule, 15 mm
Used for multiple myeloma and mantle-cell lymphoma
-
F 43
Atomoxetine 25 mg
Blue & white, capsule, 14 mm
Used for ADHD
-
SG 422
Fluoxetine Hydrochloride 60 mg
Blue, capsule, 14 mm
Used for panic disorder and OCD
-
B30
Cyclobenzaprine Hydrochloride 30 mg
Blue & red, capsule, 14 mm
Used for muscle stiffness (spasticity) and muscle spasms
-
1190
Tolterodine 4 mg
Blue, capsule, 15 mm
Used for bladder leaks
-
West ward 118
Colchicine 0.6 mg
Blue, capsule, 13 mm
Used for gout and amyloidosis
Other Metoprolol Tartrate and Hydrochlorothiazide pills
- M 434 Metoprolol Tartrate and Hydrochlorothiazide 100 mg / 25 mg Orange, oval, 15 mm Used for high blood pressure and quitting smoking
- L 232 Metoprolol Tartrate and Hydrochlorothiazide 100 mg / 25 mg White, oval, 18 mm Used for high blood pressure and quitting smoking
- S 368 Metoprolol Tartrate and Hydrochlorothiazide 100 mg / 25 mg Pink, capsule, 17 mm Used for high blood pressure and quitting smoking
- LOPHCT 461 461 Metoprolol Tartrate and Hydrochlorothiazide 100 mg / 25 mg Pink & white, capsule, 14 mm Used for high blood pressure and quitting smoking
- A 48 Metoprolol Tartrate and Hydrochlorothiazide 100 mg / 25 mg White, oval, 19 mm Used for high blood pressure and quitting smoking
- L 231 Metoprolol Tartrate and Hydrochlorothiazide 100 mg / 50 mg White, capsule, 17 mm Used for high blood pressure and quitting smoking
- S 369 Metoprolol Tartrate and Hydrochlorothiazide 100 mg / 50 mg Yellow, capsule, 17 mm Used for high blood pressure and quitting smoking
- LOPHCT 462 462 Metoprolol Tartrate and Hydrochlorothiazide 100 mg / 50 mg White & yellow, capsule, 14 mm Used for high blood pressure and quitting smoking